Park Medi World Q1 FY27 Results

Park Medi World reported Q1 FY27 revenue of ₹476 crore, marking a 19% year-on-year increase. EBITDA stood at ₹126 crore, with a healthy margin of 26.5%, and Profit After Tax (PAT) was ₹89 crore, showing an 18.6% margin.

Reader Takeaway: Strong revenue growth driven by capacity expansion, while managing occupancy dilution from new beds.

What just happened

Park Medi World announced its financial results for the first quarter of FY27. Key highlights include a 19% YoY increase in revenue to ₹476 crore, driven by volume growth and operational ramp-ups. The company achieved an EBITDA of ₹126 crore and a PAT of ₹89 crore, with margins expanding by 220 basis points YoY for PAT.

Why this matters

The company is executing an aggressive expansion strategy, increasing its total bed capacity to 3,960 as of June 30, 2026. Planned additions include 1,490 beds in calendar year 2026, targeting 4,740 beds by FY27 and 5,740 by FY28. Recent additions include commissioning The Medicity Hospital in Rudrapur and an acquisition agreement for Mehar Hospital.

The backstory

Park Medi World has been focused on scaling its healthcare network. The current expansion phase builds on its existing infrastructure. The company is utilizing internal accruals and previous IPO proceeds to fund its capital-intensive expansion, aiming to avoid new debt.

What changes now

Investors can expect continued capacity additions and potential integration of acquired assets. The company has provided guidance for FY27, expecting ₹2,080 crore in revenue, ₹530 crore in EBITDA, and ₹360 crore in PAT. The benefits from the CGHS rate hike are expected to be reinvested in capex and maintenance.

Risks to watch

Management noted that network occupancy was 56%, with a temporary dilution due to rapid new capacity addition. The ramp-up of these new beds and achieving target occupancy levels will be crucial for sustained profitability.

Peer comparison

While specific peer data is not provided in the filing, the company's aggressive bed addition strategy suggests a focus on market share growth within the Indian healthcare sector.

Context metrics (time-bound)

• Total Beds: 3,960 (June 30, 2026)
• New Beds Planned (CY2026): 1,490
• Target Beds (FY27): 4,740
• Target Beds (FY28): 5,740
• Q1 FY27 Revenue: ₹476 crore (19% YoY growth)
• Q1 FY27 EBITDA: ₹126 crore (26.5% margin)
• Q1 FY27 PAT: ₹89 crore (18.6% margin)
• ARPOB: ₹30,444 (12% YoY growth)
• ALOS: 5.9 days (improved from 6.4 days)

What to track next

Investors should monitor the ramp-up of new capacities, occupancy rates, and the successful integration of Mehar Hospital. Tracking progress against the FY27 guidance will also be key.